- Report
- December 2021
- 172 Pages
Global
From €3044EUR$3,185USD£2,590GBP
€4348EUR$4,550USD£3,700GBP
- Report
- August 2020
- 105 Pages
Europe
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- August 2020
- 97 Pages
North America
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- August 2020
- 153 Pages
Asia Pacific
From €2007EUR$2,100USD£1,708GBP
€2867EUR$3,000USD£2,439GBP
- Report
- June 2020
- 180 Pages
Global
From €3044EUR$3,185USD£2,590GBP
€4348EUR$4,550USD£3,700GBP
- Report
- April 2023
- 115 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Drug Pipelines
- September 2021
- 60 Pages
Global
From €1433EUR$1,500USD£1,220GBP
- Report
- January 2022
- 111 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Report
- January 2022
- 117 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Report
- January 2022
- 111 Pages
Global
From €4539EUR$4,750USD£3,862GBP
- Report
- January 2022
- 200 Pages
Global
From €7167EUR$7,500USD£6,098GBP
- Report
- January 2022
- 200 Pages
Global
From €7167EUR$7,500USD£6,098GBP
- Report
- January 2022
- 60 Pages
Global
From €3775EUR$3,950USD£3,212GBP
- Drug Pipelines
- January 2019
- 60 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Report
- August 2022
- 112 Pages
Global
From €4300EUR$4,500USD£3,659GBP
- Report
- March 2021
- 90 Pages
Global
From €4300EUR$4,500USD£3,659GBP
- Report
- January 2023
- 50 Pages
China
From €2867EUR$3,000USD£2,439GBP
- Report
- February 2018
- 5 Pages
Global
- Report
- November 2022
- 120 Pages
Global
From €2389EUR$2,500USD£2,033GBP
- Report
- March 2022
- 120 Pages
Global
From €2389EUR$2,500USD£2,033GBP
The Cough and Cold Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat symptoms of the common cold and other respiratory illnesses. These drugs are typically available over-the-counter and are used to reduce the severity of symptoms such as coughing, sneezing, sore throat, and congestion. Common ingredients in these medications include decongestants, antihistamines, expectorants, and pain relievers.
The Cough and Cold Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in this market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Novartis, and Sanofi. These companies have a wide range of products available, from traditional medications to more innovative treatments. Additionally, many smaller companies are also active in this market, offering more specialized products. Show Less Read more